220 related articles for article (PubMed ID: 26313006)
1. Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.
Rajasekaran D; Siddiq A; Willoughby JL; Biagi JM; Christadore LM; Yunes SA; Gredler R; Jariwala N; Robertson CL; Akiel MA; Shen XN; Subler MA; Windle JJ; Schaus SE; Fisher PB; Hansen U; Sarkar D
Oncotarget; 2015 Sep; 6(28):26266-77. PubMed ID: 26313006
[TBL] [Abstract][Full Text] [Related]
2. Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence.
Willoughby JLS; George K; Roberto MP; Chin HG; Stoiber P; Shin H; Pedamallu CS; Schaus SE; Fitzgerald K; Shah J; Hansen U
BMC Cancer; 2020 Jun; 20(1):552. PubMed ID: 32539694
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression.
Chin HG; Ponnaluri VK; Zhang G; Estève PO; Schaus SE; Hansen U; Pradhan S
Oncotarget; 2016 Dec; 7(50):83627-83640. PubMed ID: 27845898
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma.
Grant TJ; Bishop JA; Christadore LM; Barot G; Chin HG; Woodson S; Kavouris J; Siddiq A; Gredler R; Shen XN; Sherman J; Meehan T; Fitzgerald K; Pradhan S; Briggs LA; Andrews WH; Sarkar D; Schaus SE; Hansen U
Proc Natl Acad Sci U S A; 2012 Mar; 109(12):4503-8. PubMed ID: 22396589
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
6. Targeting late SV40 factor: is the achilles heel of hepatocarcinogenesis revealed?
Shlomai A
World J Gastroenterol; 2012 Dec; 18(46):6709-11. PubMed ID: 23239907
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.
Santhekadur PK; Rajasekaran D; Siddiq A; Gredler R; Chen D; Schaus SE; Hansen U; Fisher PB; Sarkar D
Am J Cancer Res; 2012; 2(3):269-85. PubMed ID: 22679558
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma.
Yoo BK; Emdad L; Gredler R; Fuller C; Dumur CI; Jones KH; Jackson-Cook C; Su ZZ; Chen D; Saxena UH; Hansen U; Fisher PB; Sarkar D
Proc Natl Acad Sci U S A; 2010 May; 107(18):8357-62. PubMed ID: 20404171
[TBL] [Abstract][Full Text] [Related]
10. Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins.
Yunes SA; Willoughby JLS; Kwan JH; Biagi JM; Pokharel N; Chin HG; York EA; Su KC; George K; Shah JV; Emili A; Schaus SE; Hansen U
PLoS One; 2022; 17(6):e0268857. PubMed ID: 35704642
[TBL] [Abstract][Full Text] [Related]
11. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
12. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
[TBL] [Abstract][Full Text] [Related]
13. Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
Saber S; Mahmoud AAA; Goda R; Helal NS; El-Ahwany E; Abdelghany RH
Toxicol Lett; 2018 Oct; 295():32-40. PubMed ID: 29859236
[TBL] [Abstract][Full Text] [Related]
14. c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF.
Yoo BK; Gredler R; Chen D; Santhekadur PK; Fisher PB; Sarkar D
J Hepatol; 2011 Dec; 55(6):1317-24. PubMed ID: 21703197
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression.
Quiles-Perez R; Muñoz-Gámez JA; Ruiz-Extremera A; O'Valle F; Sanjuán-Nuñez L; Martín-Alvarez AB; Martín-Oliva D; Caballero T; Muñoz de Rueda P; León J; Gonzalez R; Muntané J; Oliver FJ; Salmerón J
Hepatology; 2010 Jan; 51(1):255-66. PubMed ID: 20034026
[TBL] [Abstract][Full Text] [Related]
16. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
Wei W; Chua MS; Grepper S; So S
Int J Cancer; 2010 May; 126(10):2426-36. PubMed ID: 19662654
[TBL] [Abstract][Full Text] [Related]
17. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
18. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
[TBL] [Abstract][Full Text] [Related]
19. Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).
Santhekadur PK; Gredler R; Chen D; Siddiq A; Shen XN; Das SK; Emdad L; Fisher PB; Sarkar D
J Biol Chem; 2012 Jan; 287(5):3425-32. PubMed ID: 22167195
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
Yu J; Shen B; Chu ES; Teoh N; Cheung KF; Wu CW; Wang S; Lam CN; Feng H; Zhao J; Cheng AS; To KF; Chan HL; Sung JJ
Hepatology; 2010 Jun; 51(6):2008-19. PubMed ID: 20512989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
